TMED2 and cancer: Additionally, analysis of the MuTarget dataset revealed disparities in the expression of TMED2 between mutant and wild-type (WT) groups in various cancers, shedding light on potential mutation mechanisms affecting TMED2 expression during tumorigenesis.